Fiorentino et al. [47] developed a methodology that fuses omics-specific similarity networks in a single network and verified the SEC61G gene as a prognostic biomarker using gene expression, methylation, and miRNA data of GBM. This evidence concerns the gene SEC61G and glioblastoma.